SCHEMBL28103261

SCHEMBL28103261

CCCC(N)c1ccc(OC)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.47
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47
PPARA Q07869 1/20 0.47
CA2 P00918 2/20 0.44
CA1 P00915 1/20 0.44
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13981506 1.00 ACHE (0.47) ACHEPPARGPPARDPPARACA2
SCHEMBL4862475 0.90 ACHE (0.45) ACHEPPARGPPARDPPARACA2
SCHEMBL14032377 0.87 ACHE (0.51) ACHEPPARGPPARDPPARACA2
SCHEMBL12898700 0.87 SLC2A1 (0.54) ACHEPPARGPPARDPPARACA2
Hydrochloric Acid SCHEMBL10440707 0.85 SLC2A1 (0.56) ACHEPPARGPPARDPPARACA2
Hydrochloric Acid SCHEMBL5117534 0.85 ACHE (0.50) ACHEPPARGPPARDPPARACA2
SCHEMBL3465336 0.85 HTR2A (0.41) ALDH1A1MAPTGAA
SCHEMBL16649296 0.85 TAS1R3 (0.48) LMNAMEN1KMT2A
SCHEMBL29572058 0.85 TAS1R3 (0.48) LMNAMEN1KMT2A
SCHEMBL3465196 0.85 HTR2A (0.41) ALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459032-B Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection 豪夫迈·罗氏有限公司 2019-04-05 CN disclosed
CN-105899508-B Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2017-07-04 CN disclosed
CN-106459032-A Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2017-02-22 CN disclosed
CN-105899508-A Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection 豪夫迈·罗氏有限公司 2016-08-24 CN disclosed